| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |